Status:
COMPLETED
The Canadian Respiratory Research Network Long COVID-19 Study
Lead Sponsor:
Sunnybrook Health Sciences Centre
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
SARS-CoV-2 Infection
Post-acute Sequelae of SARS-CoV-2
Eligibility:
All Genders
18+ years
Brief Summary
Preliminary studies suggest that COVID-19 causes long-term lung damage, even in young, otherwise healthy people who did not need to go to hospital or the ICU. We seek to know how common long-term lun...
Detailed Description
We will prospectively recruit a representative, random sample of adult (age ≥ 18), community-dwelling patients, who have had a positive PCR test for COVID-19 infection and symptomatic infection five t...
Eligibility Criteria
Inclusion
- Aged ≥18
- Community dwelling
- First occurrence of a positive diagnostic test for SARS-CoV-2 infection (i.e., PCR or rapid antigen test, including at-home rapid antigen test) and symptomatic infection 5-12 months previously
- Consent provided
- Willing and able to go to study site for pulmonary function testing including oscillometry
Exclusion
- \- Not able to communicate with our research personnel (themselves or through a translator)
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT05181670
Start Date
August 1 2022
End Date
June 30 2024
Last Update
May 21 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Paul's Hospital
Vancouver, British Columbia, Canada
2
Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada
3
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada
4
Kingston Health Sciences Centre
Kingston, Ontario, Canada